EnClear Therapies logo

EnClear Therapies Funding & Investors

Cambridge, MA

EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the C... Read more

encleartherapies.com

Total Amount Raised: $17,718,332

EnClear Therapies Funding Rounds

  • Grant

    $5,000,000

    Grant Investors

    National Cancer Institute
    National Institute of Neurological Disorders and Stroke (NINDS)
  • Series Unknown

    $718,331

  • Series A

    $10,000,000

    Series A Investors

    20/20 HealthCare Partners
    Global Health Sciences Venture Fund
    Peter Thiel
    Thiel Capital
    Presight Capital
    Amgen
    Dolby Family Ventures
    Quark Venture
    Tachyon Ventures
    Bioverge
  • Seed

    $2,000,000

    Seed Investors

    Presight Capital
    Thiel Capital
    Bioverge
    Sanford Biosciences
Funding info provided by Diffbot.